Medical Methods for Termination of Pregnancy: Report of a WHO Scientific Group
A state-of-the-art report on the use of pharmaceutical agents and other non-invasive methods for the medical termination of pregnancy. Addressed to service managers, the report draws together a wealth of recent findings useful in evaluating the safety, efficacy, cost-effectiveness and acceptability of medical methods, whether currently in use or undergoing clinical trials. Information on established surgical procedures for abortion is also provided to facilitate comparisons and balanced decisions.
While noting that the prevention of unwanted pregnancies remains the first public health priority, the report aims to help health care personnel providing legal abortion services to determine whether these newer medical methods can improve the management of abortion in specific patient groups and in different resource settings. Over 250 references to the literature are included.
The report has eight sections. The first, on the demography of abortion, explores the many factors that contribute to unwanted pregnancies and influence abortion rates. Section two, on mechanisms for medical abortion, explains how pharmaceutical agents act to interrupt the pregnancy process and cause the pregnancy to end. Of particular value is a review of some 18 agents categorized as prostaglandins; antiprogestogens, including mifepristone; epostane; oxytocin; hypertonic agents; ethacridine lactate; hydrophilic cervical dilators; and cervical ripening devices. Each is profiled in terms of its mechanisms of action, efficacy, side-effects and safety, mode of administration, and advantages and disadvantages when compared with other medical and surgical methods. Against this background, the main part of the report provides detailed information on the current or potential place of medical methods for abortion at up to 9 weeks of gestation, at 9-14 weeks of gestation, and after 14 weeks of gestation. In each section, conclusions and recommendations identify methods of choice and their most acceptable alternatives, summarize procedures that can enhance safety, and point out factors that should be considered when selecting a method for routine use. Needs for further research are also identified.
Subsequent sections discuss the complications of abortion and measures for their prevention, and review findings from several recent studies of the acceptability - to both women and service providers - of medical abortion. The final section provides a guide to the introduction of medical abortion as a routine clinical service.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Mechanisms for medical abortion
Methods of abortion up to 63 days of amenorrhoea
5 other sections not shown
14 weeks 24 hours 49 days 63 days abor abortion by dilatation abortion by vacuum abortion process abortion rate abortion services administration amenorrhoea anaesthesia associated bleeding blood loss carboprost catheter cervical dilatation cervical injury cervical preparation choice clinical complete abortion contraception curettage days of amenorrhoea developing countries dilatation and evacuation dinoprost dinoprostone dose early medical abortion ectopic pregnancy effective ethacridine lactate factors family planning fetus first-trimester abortion gemeprost haemorrhage hospital hydrophilic dilators hypertonic hypertonic saline hysterotomy incomplete evacuation induced abortion induction-to-abortion interval intra-amniotic hypertonic intra-amniotic injection intramuscular intravenous journal of obstetrics laminaria maternal medical methods meteneprost methods of abortion methyl ester mifepristone misoprostol morbidity obstetrics and gynaecology oxytocin pessaries procedure products of conception progesterone prostaglandin analogue randomized reproductive Research result risk safe Scientific Group second-trimester abortion staff sulprostone surgical abortion surgical method tion trimester uterine injury uterus vacuum aspiration Vacuum Women vaginal pessaries weeks of gestation woman